Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Funding success for Life Science Research in Vienna

30.01.2014
The Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences (OeAW) and the Research Institute of Molecular Pathology (IMP) in Vienna reach a top score in European research funding. Together they secure seven new ERC grants.

Grants from the European Research Council (ERC) are in high demand among scientists. Securing one of them means that a project receives between 1.5 and 2.5 Million Euro of funding over a period of five years.

Applications undergo a rigorous evaluation procedure and success rates in the life sciences are typically around ten percent. The IMP and IMBA, two basic research institutes in Vienna, have received approval for all seven proposals they submitted in 2013, earning them a top score in last year’s statistics of grant distribution.

Young investigators in Europe face the problem of insufficient opportunities for an important transition: The step from working under supervision to becoming an independent researcher. ERC Starting Grants from the European Union support promising scientists at this stage in their career and encourage them to stay in Europe. ERC Consolidator Grants help researchers at a more advanced phase of their career to consolidate their own independent research team or program. ERC Advanced Grants allow established research leaders to pursue ground-breaking, high risk projects and ensure financial support of their work. Proposals for all three funding schemes are evaluated by international peer reviewers on the basis of excellence as the sole criterion.

At the IMP, applications for three ERC starting Grants were submitted in 2013. Its partner-institute IMBA applied for a total of four ERC grants – one Advanced Grant, two Starting Grants and one Consolidator Grant. All proposals of the two institutes were accepted. The grantees are:

• Luisa Cochella, IMP (ERC Starting Grant)
• David Keays, IMP (ERC Starting Grant)
• Johannes Zuber, IMP (ERC Starting Grant)
• Stefan Ameres, IMBA (ERC Starting Grant)
• Kikue Tachibana-Konwalski, IMBA (ERC Starting Grant)
• Fumiyo Ikeda, IMBA (ERC Consolidator Grant)
• Josef Penninger, IMBA (ERC Advanced Grant)
In total, 9860 grants were submitted to the ERC in 2013. Out of these, 896 proposals were selected for funding - equivalent to an overall success rate of 9 percent. With an acceptance rate of 100 percent, the scientists at the IMP and IMBA strengthen Vienna`s position as one of Europe’s top places for research in the biological sciences. This status is further supported by the fact that all life science Starting Grants awarded to Austrian institutions in 2013 went to the Campus Vienna Biocenter, where IMP and IMBA are located.
About IMP
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 36 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology.
About IMBA
The Institute of Molecular Biotechnology (IMBA) combines fundamental and applied research in the field of biomedicine. Interdisciplinary research groups address functional genetic questions, particularly those related to the origin of disease. IMBA is a subsidiary of the Austrian Academy of Sciences, the leading organization promoting non-university academic basic research in Austria. IMBA was voted second best international workplace for postdoctoral researchers by readers of the US magazine “The Scientist”.
Press Contact IMP
Dr. Heidemarie Hurtl
IMP Communications
Tel. +43 (0)1 79730-3625
E-mail: hurtl@imp.ac.at

Press Contact IMBA
Elena Bertolini, MA
IMBA Communications
Tel. +43 (0)1 79730-3824
E-mail: elena.bertolini@imba.oeaw.ac.at

Dr. Heidemarie Hurtl | idw
Further information:
http://www.imba.oeaw.ac.at
http://www.imp.ac.at

More articles from Awards Funding:

nachricht Yuan Chang and Patrick Moore win prize for the discovery of two cancer viruses
14.03.2017 | Goethe-Universität Frankfurt am Main

nachricht BMBF funding for diabetes research on pancreas chip
08.02.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>